Although the increasing number of mechanisms of action for PVT1 and its interaction with MYC in cancer are being discovered, there is no application for PVT1 in clinical treatment to date, and only one clinical trial on PVT1 is recruiting subjects. The gene discussed is PVT1; the disease is cancer.